Sarah Miksinski
General Counsel at GILEAD SCIENCES, INC.
Profile
Sarah C.
Pope Miksinski is currently working as an Executive Director-CMC Regulatory Affairs at Gilead Sciences, Inc. and as a Director at International Society for Pharmaceutical Engineering.
She previously worked as a Senior Director-Global Regulatory Affairs at AstraZeneca PLC.
Sarah Miksinski active positions
Companies | Position | Start |
---|---|---|
GILEAD SCIENCES, INC. | General Counsel | - |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Director/Board Member | - |
Former positions of Sarah Miksinski
Companies | Position | End |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
- Stock Market
- Insiders
- Sarah Miksinski